CRIS Current Research Information System

BUONTEMPO, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.366
EU - Europa 1.559
AS - Asia 915
AF - Africa 102
SA - Sud America 9
OC - Oceania 3
Totale 4.954
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.363
GB - Regno Unito 421
CN - Cina 328
IT - Italia 284
SE - Svezia 276
VN - Vietnam 271
DE - Germania 203
SG - Singapore 172
IN - India 77
IE - Irlanda 70
RU - Federazione Russa 62
FR - Francia 58
UA - Ucraina 46
TG - Togo 41
ZA - Sudafrica 41
EE - Estonia 35
JO - Giordania 30
CH - Svizzera 25
IR - Iran 20
BG - Bulgaria 18
BE - Belgio 14
FI - Finlandia 11
AT - Austria 10
CI - Costa d'Avorio 9
CL - Cile 9
NG - Nigeria 6
PT - Portogallo 5
RO - Romania 5
LB - Libano 4
CA - Canada 3
ES - Italia 3
ID - Indonesia 3
NL - Olanda 3
PL - Polonia 3
AU - Australia 2
CZ - Repubblica Ceca 2
EG - Egitto 2
GR - Grecia 2
KR - Corea 2
TR - Turchia 2
HK - Hong Kong 1
HR - Croazia 1
IL - Israele 1
JP - Giappone 1
LK - Sri Lanka 1
MA - Marocco 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 4.954
Salva come PNG Salva come JPEG
Città #
Southend 384
Fairfield 278
Ashburn 197
Chandler 196
Dong Ket 173
Houston 170
Woodbridge 154
Singapore 150
Wilmington 143
Bologna 132
Seattle 132
Santa Clara 118
Ann Arbor 108
Cambridge 91
Princeton 84
Dublin 70
Boardman 55
Lomé 41
Nanjing 41
New York 41
Westminster 41
Padova 36
Amman 30
Berlin 25
Bern 24
Bremen 24
Jinan 24
Beijing 22
Shenyang 21
Jacksonville 19
Saint Petersburg 19
Changsha 18
Sofia 18
Turin 14
Brussels 13
Falls Church 13
Nanchang 13
Florence 12
Redmond 12
Helsinki 11
Guangzhou 10
Haikou 10
Hangzhou 10
Hebei 10
Medford 10
Norwalk 10
San Diego 10
Zhengzhou 10
Abidjan 9
Frankfurt am Main 8
Jiaxing 8
Tianjin 8
Vienna 8
Dearborn 7
Mülheim 7
Ningbo 7
Pune 7
Rome 7
Shanghai 7
Abeokuta 6
Fuzhou 6
Los Angeles 5
Redwood City 5
Washington 5
Andover 4
Clearwater 4
Kuban 4
London 4
Olalla 4
Plauen 4
Zanjan 4
Bühl 3
Castiglione Delle Stiviere 3
Chieri 3
Hefei 3
Jakarta 3
Kashan 3
Kish 3
Kunming 3
Milan 3
Mountain View 3
San Francisco 3
Taiyuan 3
Trapani 3
Trento 3
Borgoricco 2
Bucharest 2
Casalecchio di Reno 2
Cedar Knolls 2
Chengdu 2
Chicago 2
Den Haag 2
Dongguan 2
Düsseldorf 2
Ferrara di Monte Baldo 2
Fort Worth 2
Kiev 2
La Florida 2
Lisbon 2
Ludwigshafen 2
Totale 3.457
Salva come PNG Salva come JPEG
Nome #
9-Hydroxystearic acid upregulates p21WAF1 in HT29 cancer cells. 202
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: from biology to therapeutic targeting. 190
Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia 186
Characterization of biological effects in radiotherapy applications of ultra-high dose rate pulses from a plasma focus device 179
Activity of the Selective IκB kinase Inhibitor BMS-345541 against T-Cell Acute Lymphoblastic Leukemia: involvement of FOXO3a 156
Early biological effects of ultra-high compare to standard dose rate of X-rays on a radioresistant cell line 154
Dosimetric analysis and experimental setup design for in-vivo irradiation with a Plasma Focus device 154
Therapeutic targeting of CK2 in acute and chronic leukemias. 153
Nuclear translocation of active AKT is required for erythroid differentiation in erythropoietin treated K562 erythroleukemia cells. 146
Autophagy in acute leukemias: a double-edged sword with important therapeutic implications. 145
Improving nelarabine efficacy in T-cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway. 139
Antioxidants in the prevention of UVB-induced keratynocyte apoptosis. 135
Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells. 132
Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device 132
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling 128
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. 127
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia 125
Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia. 123
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 122
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 121
Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies. 121
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 120
Nuclear phosphoinositides and their roles in cell biology and disease. 115
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia 107
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival er chaperone BIP/GRP78 and turning on the pro-apoptotic NF-κB. 106
GSK-3β: a key regulator of breast cancer drug resistance 104
Drug discovery targeting the mTOR pathway 100
null 95
Protective effect of different antioxidant agents in UVB-irradiated keratinocytes 95
Diet modulation restores autophagic flux in damaged skeletal muscle cells. 95
Marine bisindole alkaloid: a potential apoptotic inducer in cancer cells. 89
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. 88
null 83
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels. 83
Inhibition of Akt signaling in hepatoma cells induces apoptotic cell death independent of Akt activation status 80
null 75
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 71
Dose-current discharge correlation analysis in a Mather type Plasma Focus device for medical applications 67
Estrogen-deficient osteoporosis enhances the recruitment and activity of osteoclasts by breast cancer cells 67
null 61
null 52
null 45
null 43
Compact and very high dose-rate plasma focus radiation sources for medical applications 40
INHIBITION OF PROLIFERATION AND SURVIVAL IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) CELLS REQUIRES BLOCKADE OF ALL THE CLASS I PI3Ks ISOFORMS 40
EVALUATION OF THE EFFICACY AND ANTITUMOR ACTIVITY OF THE PAN-CLASS I PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) INHIBITOR NVP-BKM120 IN HUMAN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) 32
HNE protein adducts and apoptosis in osteosarcoma cells 29
INHIBITION OF CLASS I PHOSPHATIDYLINOSITOL 3-KINASES (PI3KS) ISOFORMS IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL): WHICH IS THE BEST THERAPEUTIC STRATEGY? 24
Tyrosol prevents apoptosis in irradiated keratinocytes. 19
Totale 5.095
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.618
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.618
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020838 0 0 0 0 0 149 146 144 192 73 53 81
2020/2021657 122 47 15 22 7 15 15 27 61 24 33 269
2021/2022969 149 19 61 59 87 49 19 62 37 127 183 117
2022/2023945 85 130 52 146 59 69 33 48 180 10 80 53
2023/2024295 21 40 26 33 27 95 5 10 7 12 8 11
2024/2025529 16 121 87 69 192 44 0 0 0 0 0 0
Totale 5.095